key: cord-0852593-aa7slcnc authors: Dong, Lianhua; Zhou, Junbo; Niu, Chunyan; Wang, Quanyi; Pan, Yang; Sheng, Sitong; Wang, Xia; Zhang, Yongzhuo; Yang, Jiayi; Liu, Manqing; Zhao, Yang; Zhang, Xiaoying; Zhu, Tao; Peng, Tao; Xie, Jie; Gao, Yunhua; Wang, Di; Zhao, Yun; Dai, Xinhua; Fang, Xiang title: Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR date: 2020-03-18 journal: nan DOI: 10.1101/2020.03.14.20036129 sha: 98ba0f8fa9ece84d4a025c70d9de89bb5f3e738e doc_id: 852593 cord_uid: aa7slcnc BACKGROUND: The outbreak of COVID-19 caused by a novel Coronavirus (termed SARS-CoV-2) has spread to over 140 countries around the world. Currently, reverse transcription quantitative qPCR (RT-qPCR) is used as the gold standard for diagnostics of SARS-CoV-2. However, the positive rate of RT-qPCR assay of pharyngeal swab samples are reported to vary from 30~60%. More accurate and sensitive methods are urgently needed to support the quality assurance of the RT-qPCR or as an alternative diagnostic approach. METHODS：We established a reverse transcription digital PCR (RT-dPCR) protocol to detect SARS-CoV-2 on 194 clinical pharyngeal swab samples, including 103 suspected patients, 75 close contacts and 16 supposed convalescents. RESULTS: The limit of blanks (LoBs) of the RT-dPCR assays were ~1.6, ~1.6 and ~0.8 copies/reaction for ORF 1ab, N and E genes, respectively. The limit of detection (LoD) was 2 copies/reaction. For the 103 fever suspected patients, the sensitivity of SARS-CoV-2 detection was significantly improved from 28.2% by RT-qPCR to 87.4% by RT-dPCR. For close contacts, the suspect rate was greatly decreased from 21% down to 1%. The overall sensitivity, specificity and diagnostic accuracy of RT-dPCR were 90%, 100% and 93 %, respectively. In addition, quantification of the viral load for convalescents by RT-dPCR showed that a longer observation period was needed in the hospital for elderly patients. CONCLUSION: RT-dPCR could be a confirmatory method for suspected patients diagnosed by RT-qPCR. Furthermore, RT-dPCR was more sensitive and suitable for low viral load specimens from the both patients under isolation and those under observation who may not be exhibiting clinical symptoms. In late December 2019, a number cases of pneumonia infection were reported in Wuhan, Hubei Province, China. It was officially named as Coronavirus disease (COVID-19) by the World Health Organization (WHO) and has since spread to 129 countries around the world till March 14, 2020 (1, 2) . The pathogen causing the outbreak of disease was identified as a novel Coronavirus (termed SARS-CoV-2), belonging to the family Coronaviridae, order Nidovirales, all of which are enveloped, non-segmented positive-sense RNA viruses (3, 4) . According to the WHO and Chinese Center for Disease Control and Prevention (CDC), the current gold standard for the diagnosis of SARS-CoV-2 infection is based on the real-time fluorescent quantitative PCR (RT-qPCR). However, RT-qPCR is reported to have issues of low positive rates for throat swab samples (5) and there were 3% of patients who had negative RT-qPCR test results at initial presentation while chest CT checks indicated typical symptoms of viral pneumonia (6) . In order to identify and hospitalize COVID-19 patients in time, more sensitive and accurate tests are required. Digital PCR (dPCR) is a technology which partitions nucleic acid molecules across a large number of smaller reactions and acquires amplification data of each partition at end point based on the intensity of fluorescence (7) (8) (9) . Quantification is performed by applying Poisson statistics to the proportion of the negative partitions to account for positive partitions that initially contained more than one target molecule. dPCR can offer greater precision than qPCR and is far simpler to use for copy number quantification due the binary nature in which the partitions are counted as positive or negative. Additionally, dPCR is more tolerant of PCR inhibition compared with qPCR due to partitioning and because it is an end-point PCR measurement and consequently less dependent on high PCR efficiency (10, 11) . In this study, we established one step RT-dPCR for detection of ORF1ab open reading frame 1ab (ORF1ab) and nucleocapsid protein (N) and E gene of SARS-CoV-2. Moreover, we compared RT-qPCR and RT-dPCR on 194 clinical samples and found RT-dPCR can significantly improve the sensitivity and accuracy of Coronavirus disease (COVID-19) diagnostics. Data collection of cases and close contacts were determined by the National Health Commission of the People's Republic of China to be part of a continuing public health outbreak investigation and were thus considered exempt from institutional review board approval. The analysis was performed on existing samples collected during standard diagnostic tests, posing no extra burden to patients. The primer and probe sequences for detecting N and ORF1ab gene target of the and analyzed using the QuantaSoft droplet reader software (V1.7.4, Bio-Rad, USA). To establish the limit of blank (LoB) (14) , 60 blank measurements were obtained from 3 blank mutant samples on three days. 70 to 76 measurements from 4 samples with low concentration (1 to3 cp/reaction) were used to determine the limit of detection (LoD) according to the CLSI guideline of EP17-A(15). the range from approximately 10 4 to 10 0 copies/reaction (Fig. 1 ). Reactions containing a mean of 60 E, 66 N or 11 ORF1ab copies fulfilled the criterion for an LoQ with a CV lower than 25%. Sixty blank measurements obtained from 6 blank samples on five days were analyzed to determine the LoB. As the distribution of the 60 blank measurements is skewed ( Figure (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 18, 2020. . statistics was used. Consequently, the LoD is determined to be 2 copies/ reaction. The Specificity of the assays for ORF1ab and E gene has been tested in a previous report. To further validate the specificity of all assays, Influenza virus were collected. All assays were tested on human clinical samples at Wuhan CDC and National institute of Metrology, China. All tests returned negative results (in table S3 ). (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 18, 2020. . negative or positive information were reported. Single gene target positive was determined to be SARS-CoV-2 positive based on parallel test with a commercial kit and Chinese CDC assays. Therefore, these 15 samples were reported positive by BJCDC. 8 qPCR negatives for ORF1ab were positive tested by dPCR, showing high sensitivity for ORF1ab by dPCR. Only 3 negatives for ORF1ab which can be complemented by E gene targets. Among the 103 specimens, 29 positive, 25 negative and 49 suspected were reported by RT-qPCR. However, 61 samples including 17 negative and 44 suspected tested by qPCR were confirmed to be positive by dPCR, thus 90 patients in total whose SARS-CoV-2 nucleic acid were positive tested can be diagnosed with COVID-19. All the 103 patients were confirmed SARS-CoV-2 infection according to a follow-up survey. The accuracy of SARS-CoV-2 detection was significantly improved from 28.2% to 87.4% (Fig. 2) . 75 specimens were collected from contacts and close contacts. 48 specimens from contacts were reported negative based qPCR test by BJCDC on Feb 6 and were confirmed by dPCR on Feb 7 in table S4. According to a follow-up survey, all of them were in good health and isolation was lifted after 14 days. 27 specimens (table 2 and Furthermore, among the 16 specimens corrected by dPCR, 6 persons (P14,18-21and P23 in table S5) were directed for secondary testing following an initial negative test 2 to 10 days prior. Based on qPCR results, further isolation and All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 18, 2020. . observation was still needed to be conducted as the testing result is suspect or negative and no clinical symptoms were observed for them. However, if based on dPCR, all the six patients can be diagnosed with COVD-19 infected by SARS-CoV-2 and treatment could be conducted earlier. This indicates dPCR is more sensitive and suitable for low virus load specimens from the patients under isolation and observation without clinical symptoms, which is in agreement with the very recent online report (19). Additionally, 16 pharyngeal swabs were collected from convalescent patients (Table 3 ). 12 positive, 3 suspect and 1 negative were reported by qPCR. However, all of these 16 patients are diagnosed to be positive by dPCR, indicating that all of them still need to be observed in hospital. Correlation between age and the RNA virus copy number was analysis (Fig.4) . Interestingly, except P15, with increasing age, the copy number of virus load was much higher, which indicates a longer observation in the hospital is needed. We set up the threshold of 15, 20 and 25 copies/reaction for ORF1ab, N and E, respectively. The ORF1ab, N and E gene copy number were higher than their threshold for 100% patients elder than 60 and 75% (6 out 8 patients) elder than 55 (the median). RT-qPCR, as the standard method of diagnostics of SARS-CoV-2, plays an important role in this outbreak, though a low positive rate has been reported (5) . A number of factors could affect RT-PCR testing results including sample collection and transportation, RNA extraction and storage, and proper performance of the kit (20) . More recently, more than 145 RT-qPCR kits have been developed by the in vitro diagnostic manufactures (IVDs) in China (21). Among the qPCR kits, those with low sensitivity would cause high false negative rate or high equivocal rate. For the equivocal results it is necessary to conduct a retest, but due to the daily burden of thousands of incoming samples it is often impossible to do a same day retest. The testing laboratory should initially report a result based on a single test, while secondary sampling for a later retest does not need to be sent to the same laboratory. Therefore, availability of a highly sensitive and accurate confirmatory method is of All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 18, 2020. . This work demonstrates that dPCR significantly improves accuracy and reduces the false negative rate of diagnostics of SARS-CoV-2, which could be a powerful complement to the current RT-qPCR. Furthermore, dPCR is more sensitive and suitable for low virus load specimens from the patients under isolation and observation who may not be exhibiting clinical symptoms. Research Funding: Fundamental Research Funds for Central Public welfare All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 18, 2020. . (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 18, 2020. . All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 18, 2020. . (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 18, 2020. . (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 18, 2020. . copies/reaction for ORF1ab, N and E, respectively. The ORF1ab, N and E gene copy number were higher than their threshold for 100% patients elder than 60 and 75% (6 out 8 patients) elder than 55 (the median). (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 18, 2020. . All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 18, 2020. . (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 18, 2020. . All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 18, 2020. . Retinal vegf mrna measured by sybr green i fluorescence: A versatile approach to quantitative pcr An overview of their replication and pathogenesis Recent insights into 2019-ncov: A brief but comprehensive review Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis andmonitoring the viral shedding of 2019-ncov infections Chest ct for typical 2019-ncov pneumonia: Relationship to negative rt-pcr testing High-throughput droplet digital pcr system for absolute quantitation of DNA copy number Absolute quantification by droplet digital pcr versus analog real-time pcr Digital pcr Tolerance of droplet-digital pcr vs real-time quantitative pcr to inhibitory substances Highly precise measurement of hiv DNA by droplet digital pcr Interlaboratory assessment of droplet digital pcr for quantification of braf v600e mutation using a novel DNA reference material Protocols for determination of limits of detection and limits of quantitation The digital miqe guidelines: minimum information for publication of quantitative digital pcr experiments Taking qpcr to a higher level: Analysis of cnv reveals the power of high throughput qpcr to enhance quantitative resolution Highly precise measurement of hiv DNA by droplet digital pcr Correlation of chest ct and rt-pcr testing in coronavirus disease 2019 (covid-19) in china: A report of 1014 cases Assessment of digital pcr as a primary reference measurement procedure to support advances in precision medicine We would like to thank Academy of Military Medical Sciences for providing the purified virus RNA for method validation, Wuhan considering laboratory for medical test for conducting the dPCR measurement and BioRad, China for donating the one step RT-dPCR mastermix.